Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
Kasi PM, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J, Khan S, Wood M, Samstein B, Rocca JP, Ocean AJ, Popa EC, Hunt DH, Uppal NP, Garrett KA, Pigazzi A, Zhou XK, Shah MA, Hissong E. Kasi PM, et al. Among authors: hidalgo m. Oncogene. 2023 Oct;42(44):3252-3259. doi: 10.1038/s41388-023-02835-y. Epub 2023 Sep 21. Oncogene. 2023. PMID: 37731056 Free PMC article.
Reply to K. de Joode et al.
Brar G, Pinheiro LC, Hidalgo M, Shah MA. Brar G, et al. Among authors: hidalgo m. J Clin Oncol. 2021 Mar 20;39(9):1093-1094. doi: 10.1200/JCO.20.03530. Epub 2021 Jan 26. J Clin Oncol. 2021. PMID: 33497249 No abstract available.
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection.
Fankuchen O, Lau J, Rajan M, Swed B, Martin P, Hidalgo M, Yamshon S, Pinheiro L, Shah MA. Fankuchen O, et al. Among authors: hidalgo m. Am J Clin Oncol. 2023 Jul 1;46(7):300-305. doi: 10.1097/COC.0000000000001005. Epub 2023 Apr 19. Am J Clin Oncol. 2023. PMID: 37072891 Free PMC article.
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.
Brar G, Pinheiro LC, Shusterman M, Swed B, Reshetnyak E, Soroka O, Chen F, Yamshon S, Vaughn J, Martin P, Paul D, Hidalgo M, Shah MA. Brar G, et al. Among authors: hidalgo m. J Clin Oncol. 2020 Nov 20;38(33):3914-3924. doi: 10.1200/JCO.20.01580. Epub 2020 Sep 28. J Clin Oncol. 2020. PMID: 32986528 Free PMC article.
Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer.
Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, Hidalgo M. Shah MA, et al. Among authors: hidalgo m. JAMA Netw Open. 2020 Sep 1;3(9):e2023121. doi: 10.1001/jamanetworkopen.2020.23121. JAMA Netw Open. 2020. PMID: 32990737 Free PMC article.
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
Shah MA, Emlen MF, Shore T, Mayer S, Leonard JP, Rossi A, Martin P, Ritchie E, Niesvizky R, Pastore R, Cigler T, De Sancho M, Scheff R, Van Besien K, Roboz G, Nanus D, Goldstein P, Scrimenti L, Hidalgo M. Shah MA, et al. Among authors: hidalgo m. CA Cancer J Clin. 2020 Sep;70(5):349-354. doi: 10.3322/caac.21627. Epub 2020 Jul 14. CA Cancer J Clin. 2020. PMID: 32662880 Free PMC article.
Facts and Hopes in Immunotherapy of Pancreatic Cancer.
Bockorny B, Grossman JE, Hidalgo M. Bockorny B, et al. Among authors: hidalgo m. Clin Cancer Res. 2022 Nov 1;28(21):4606-4617. doi: 10.1158/1078-0432.CCR-21-3452. Clin Cancer Res. 2022. PMID: 35775964 Review.
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial.
Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, Golan T, Geva R, Borad MJ, Pedersen KS, Park JO, Ramirez RA, Abad DG, Feliu J, Muñoz A, Ponz-Sarvise M, Peled A, Lustig TM, Bohana-Kashtan O, Shaw SM, Sorani E, Chaney M, Kadosh S, Vainstein Haras A, Von Hoff DD, Hidalgo M. Bockorny B, et al. Among authors: hidalgo m. Nat Med. 2020 Jun;26(6):878-885. doi: 10.1038/s41591-020-0880-x. Epub 2020 May 25. Nat Med. 2020. PMID: 32451495 Clinical Trial.
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.
Hidalgo M, Garcia-Carbonero R, Lim KH, Messersmith WA, Garrido-Laguna I, Borazanci E, Lowy AM, Medina Rodriguez L, Laheru D, Salvador-Barbero B, Malumbres M, Shields DJ, Grossman JE, Huang X, Tammaro M, Martini JF, Yu Y, Kern K, Macarulla T. Hidalgo M, et al. Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970055 Free PMC article. Clinical Trial.
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Bazan-Peregrino M, Garcia-Carbonero R, Laquente B, Álvarez R, Mato-Berciano A, Gimenez-Alejandre M, Morgado S, Rodríguez-García A, Maliandi MV, Riesco MC, Moreno R, Ginestà MM, Perez-Carreras M, Gornals JB, Prados S, Perea S, Capella G, Alemany R, Salazar R, Blasi E, Blasco C, Cascallo M, Hidalgo M. Bazan-Peregrino M, et al. Among authors: hidalgo m. J Immunother Cancer. 2021 Nov;9(11):e003254. doi: 10.1136/jitc-2021-003254. J Immunother Cancer. 2021. PMID: 35149591 Free PMC article. Clinical Trial.
1,202 results